Search Results for keywords:"TFF Pharmaceuticals"

Found 1 results
Skip to main content

Search Results: keywords:"TFF Pharmaceuticals"

  • Type:Notice
    Citation:90 FR 10949
    Reading Time:about 2 minutes

    On January 16, 2025, the Rapid Response Partnership Vehicle (RRPV) filed notifications with the Attorney General and the Federal Trade Commission about its changing membership. These notifications are related to the National Cooperative Research and Production Act of 1993, which limits the recovery of damages by antitrust plaintiffs in certain situations. Several companies were added to the RRPV, including Fisher BioServices from Maryland and Matisse Pharmaceuticals from the Netherlands, among others. TFF Pharmaceuticals from Texas has withdrawn from the venture. The membership of this group remains open, and changes will continue to be reported in future notifications.

    Simple Explanation

    The Rapid Response Partnership Vehicle is a group that works together on special projects and tells the government when they have new team members. They added some new companies and one company left, and they will keep updating their team list in the future.